Amyloid-β1-42 oligomers enhance mGlu5R-dependent synaptic weakening via NMDAR activation and complement C5aR1 signaling

Ng, Ai Na; Salter, Eric W.; Georgiou, John; Bortolotto, Zuner A.; Collingridge, Graham L.

doi:10.1016/j.isci.2023.108412

Cited by 2 publications

(1 citation statement)

References 103 publications

(166 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, pharmacological inhibition of C5aR1 in the Tg2576 model of AD also rescued the excessive synaptic loss observed in this mouse model at 15 months of age in both CA3 and CA1 (Figure 5 ). These results are consistent with both the rescue of LTP (Figure 1 ) and of neuronal integrity in the Arc‐C5aR1KO mice (Supp Figure S3 and 29 ), as well as the cognitive protection observed previously with C5aR1 antagonist treatment of Tg2576 mice and the C5aR1 deficient Arctic model of AD 29 , 31 and a role for C5aR1 signaling in oligomeric Aß enhancement of LTD. 48 …”

Section: Discussionmentioning

confidence: 99%

C5aR1 signaling promotes region‐ and age‐dependent synaptic pruning in models of Alzheimer's disease

Gomez‐Arboledas,

Fonseca,

Kramar

et al. 2024

Alzheimer's & Dementia

View full text Add to dashboard Cite

INTRODUCTIONSynaptic loss is a hallmark of Alzheimer's disease (AD) that correlates with cognitive decline in AD patients. Complement‐mediated synaptic pruning has been associated with this excessive loss of synapses in AD. Here, we investigated the effect of C5aR1 inhibition on microglial and astroglial synaptic pruning in two mouse models of AD.METHODSA combination of super‐resolution and confocal and tridimensional image reconstruction was used to assess the effect of genetic ablation or pharmacological inhibition of C5aR1 on the Arctic48 and Tg2576 models of AD.RESULTSGenetic ablation or pharmacological inhibition of C5aR1 partially rescues excessive pre‐synaptic pruning and synaptic loss in an age and region‐dependent fashion in two mouse models of AD, which correlates with improved long‐term potentiation (LTP).DISCUSSIONReduction of excessive synaptic pruning is an additional beneficial outcome of the suppression of C5a‐C5aR1 signaling, further supporting its potential as an effective targeted therapy to treat AD.Highlights C5aR1 ablation restores long‐term potentiation in the Arctic model of AD. C5aR1 ablation rescues region specific excessive pre‐synaptic loss. C5aR1 antagonist, PMX205, rescues VGlut1 loss in the Tg2576 model of AD. C1q tagging is not sufficient to induce VGlut1 microglial ingestion. Astrocytes contribute to excessive pre‐synaptic loss at late stages of the disease.

show abstract